Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Transforming Bioactive Proteins into Therapeutic Products

Now into its fourth decade, PEGylation has come a long way from the original random conjugation chemistries that resulted in mixtures of PEG positional isomers with subsequent mixtures of biological activities. Continued innovation now means it is possible to more precisely control the site of PEGylation, leading to more homogeneous medicines with predictable behaviour.

By Anthony Godwin at PolyTherics Ltd (September 2009)

Keywords: bioactive proteins, therapeutic products, homogeneity, pharmacokinetics, protein formulation, biopharmaceuticals, genomics, proteomics

    View full article    |    Back to Delivery systems section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |